Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if BMRN is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
71 top institutions tracked
Last 13F trend: accumulating (light)
Unlock crowding heatmapUnlock filer discoverySentiment: neutral
Last trade: sell 42 days ago
Red flags: 1
564 filers reported a long position in BMRN for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| BlackRock, Inc. | $1.2B | 20.4M | +3.2% |
| DODGE & COX | $849.4M | 14.8M | +1.9% |
| PRIMECAP MANAGEMENT CO/CA/ | $812M | 14.2M | 0% |
| VANGUARD CAPITAL MANAGEMENT LLC | $500.3M | 8.7M | +1.2% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $494.9M | 8.6M | +4.2% |
| NORGES BANK | $469.7M | 8.2M | — |
| STATE STREET CORP | $446.4M | 7.8M | +6.9% |
| VIKING GLOBAL INVESTORS LP | $435.8M | 7.6M | +7.9% |
| Vestal Point Capital, LP | $344.8M | 6M | +68.5% |
| AQR CAPITAL MANAGEMENT LLC | $322.5M | 5.7M | -25.8% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.